.. Celleration initiates enrollment in MIST Therapy study for VLU Celleration, Inc., a privately-held medical device business focused on developing and commercializing therapeutic ultrasound healing technologies, announced the first individual enrollment in IN-Stability VLU . Related StoriesCombination of ultrasound and mammography detects additional cancers in Japanese womenMesenchymal stem cell exosomes give hope in healing chronic woundsClinical trial initiated to determine feasibility, basic safety of concentrated ultrasound to treat depressionIN-Stability VLU is a prospective, randomized, controlled, multi-center study of MIST Therapy in chronic lower extremity venous ulcers .Jointly, they could deliver a good one-two punch that may be important in further reducing heart disease. Dr. Ley said antigen-presenting cells consider up infectious organisms, foreign materials and self-proteins and chop them into small parts called epitopes and then display the pieces on the surface of the cell. The T cell comes along, and if it gets the correct receptors, it will recognize the epitope pieces and make cytokines that strike the material and trigger inflammation. Autoimmune diseases include such illnesses as type 1 diabetes, arthritis rheumatoid and multiple sclerosis. In the scholarly study, Dr. Ley and his team used live cell imaging ways to track immune cells in artherosclerotic and normal mouse aortas. He said in mice with atherosclerosis, there are always a large numbers of antigen-experienced T cells that have already seen specific epitope pieces that they perceive as international.